Open the full-size image ↗

This global pharmaceutical powerhouse manages massive drug trials worldwide - for example, leading the global 64,000-patient Pfizer/BioNTech vaccine trial. They engaged Jim for a CEO-level event to challenge the organization to identify the strategic opportunity of becoming fully AI-enabled - and how they might disrupt its business model before it is disrupted.